Poland· PL-100427712

Bijuva

A progesteron und estrogen product containing estradiolum + progesteronum, registered in Poland by Theramex Ireland Limited. The same ATC class is registered in 5 of our 19 countries.

ATC G03FA04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBijuvaATCG03FA04REGISTER NO.PL-100427712PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Progesteron und estrogen is registered in 5 of 19 countries.

Countries holding a registration under ATC G03FA04 (progesteron und estrogen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Progesteron und estrogen · ATC G03FA04

5 / 19 countries

  • Belgiumprice
  • Canada
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Estradiolum + Progesteronum
Manufacturer
Theramex Ireland Limited
Country
Poland (PL)
ATC code
G03FA04
ATC class
Progesteron und Estrogen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05060632508966
  • gtin
    05060632509055

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Progesteron und estrogen in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All progesteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Belgium · Duogestan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0a41e3a-bf7a-45a1-9639-ba89ae03c9f0
GET /v1/drugs/c0a41e3a-bf7a-45a1-9639-ba89ae03c9f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "1 mg + 100 mg",
  "packaging": "05060632508966 ¦ Rp ¦ 140682\n28 kaps.\n05060632509055 ¦ Rp ¦ 140683\n84 kaps.",
  "substance": "Estradiolum 1 mg + Progesteronum 100 mg",
  "common_name": "Estradiolum + Progesteronum",
  "pl_product_id": "100427712",
  "pozwolenie_nr": "26471",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about progesteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.